Actuate Therapeutics | 4/A:持股变动声明(修正)-董事 Bios Equity COF, LP
Actuate Therapeutics | 4/A:持股变动声明(修正)-董事 Fletcher Aaron G.L.
Actuate Therapeutics | 4/A:持股变动声明(修正)-股东 Kreis Leslie W.
Actuate Therapeutics | SC 13D:超过5%持股股东披露文件-AARON GLENN LOUIS FLETCHER(52.8%),BIOS CAPITAL MANAGEMENT, LP(52.4%)等
Actuate Therapeutics | 4:持股变动声明-董事 THOMSON TODD S
Actuate Therapeutics | 4:持股变动声明-董事 Bios Equity COF, LP
Actuate Therapeutics | 4:持股变动声明-董事 Bios Equity COF, LP
Actuate Therapeutics | 4:持股变动声明-董事 Fletcher Aaron G.L.
Actuate Therapeutics | 4:持股变动声明-董事 Fletcher Aaron G.L.
Actuate Therapeutics | 4:持股变动声明-股东 Kreis Leslie W.
Actuate Therapeutics | 4:持股变动声明-股东 Kreis Leslie W.
Actuate Therapeutics | 3:首次持股声明-董事 Bios 2024 Co-Invest, LP
Actuate Therapeutics | 4:持股变动声明-董事 Zabrowski Dan
Actuate Therapeutics | 4:持股变动声明-高管 SCHMITT DANIEL M
Actuate Therapeutics | 4:持股变动声明-高管 LYTLE PAUL J
Actuate Therapeutics | 4:持股变动声明-董事 Keyes Jason A
Actuate Therapeutics | 4:持股变动声明-董事 RONNEBERG AMY L
Actuate Therapeutics | 4:持股变动声明-董事 Sawhney Roger
Actuate Therapeutics | 3:首次持股声明-董事 RONNEBERG AMY L
Actuate Therapeutics | 3:首次持股声明-董事 Sawhney Roger
暂无数据
暂无数据